The Global Newborn Screening and Genetic Services Market was valued at USD 1.21 Billion in 2023 and is projected to reach USD 2.18 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period (2024–2030). This robust growth is propelled by increasing awareness of hereditary disorders, technological advancements in genomic testing, and supportive government initiatives mandating newborn screening programs worldwide.

As healthcare systems globally pivot towards preventive and precision medicine, the role of advanced newborn screening has never been more critical. These services are the first line of defense against debilitating and often life-threatening conditions, enabling early intervention and significantly improving lifelong health outcomes. In this blog, we profile the Top 10 Companies in the Newborn Screening and Genetic Services Industry—a dynamic group of diagnostic giants, medical device leaders, and specialized service providers shaping the future of pediatric health.

Download FREE Sample Report:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

🔟 1. PerkinElmer, Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Screening Instruments, Reagents, Software, and Integrated Solutions

PerkinElmer is a global leader in newborn screening, providing end-to-end solutions that include advanced tandem mass spectrometry systems, immunoassays, and data management software. Their solutions are used by public health laboratories in over 100 countries to screen for more than 50 disorders.

Innovation and Growth Initiatives:

• Development of next-generation sequencing (NGS) panels for comprehensive genetic screening

• Expansion of digital health platforms for real-time result tracking and reporting

• Strategic acquisitions to enhance genomic analysis capabilities

---

9️⃣ 2. Bio-Rad Laboratories, Inc.

Headquarters: Hercules, California, USA
Key Offering: HPLC Systems, Quality Controls, Automation Platforms, and Test Kits

Bio-Rad is a cornerstone of the newborn screening ecosystem, known for its high-quality hemoglobin testing products and quality control materials. Their systems are essential for detecting sickle cell disease and other hemoglobinopathies, which are core components of screening panels in many nations.

Innovation and Growth Initiatives:

• Pioneering digital PCR technology for ultra-sensitive genetic mutation detection

• Global partnerships with public health agencies to standardize screening protocols

Download FREE Sample Report:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

8️⃣ 3. Waters Corporation

Headquarters: Milford, Massachusetts, USA
Key Offering: Tandem Mass Spectrometry (MS/MS) Systems and Consumables

Waters Corporation provides critical analytical instrumentation that forms the backbone of modern metabolic screening. Their robust and sensitive mass spectrometers enable laboratories to accurately measure amino acids, acylcarnitines, and other biomarkers from a single dried blood spot.

Innovation and Growth Initiatives:

• Continuous innovation in MS/MS platform sensitivity and throughput

• Development of integrated software solutions for automated data interpretation

---

7️⃣ 4. Trivitron Healthcare

Headquarters: Chennai, India
Key Offering: Newborn Screening Kits, Hearing Screeners, Pulse Oximeters, and Lab Equipment

Trivitron Healthcare is a major player, particularly in emerging markets, offering a comprehensive portfolio of affordable and accessible screening technologies. The company is instrumental in expanding screening programs across Asia, the Middle East, and Africa.

Innovation and Growth Initiatives:

• Focus on developing cost-effective screening solutions for low-resource settings

• Manufacturing a wide range of medical devices and in-vitro diagnostics locally

---

6️⃣ 5. Natus Medical Incorporated

Headquarters: Pleasanton, California, USA
Key Offering: Hearing Screening Devices, EEG Systems, and Cool Cap Therapy

Natus Medical specializes in neurodiagnostics and newborn care, with a strong focus on hearing screening. Their products are used in hospitals worldwide to identify hearing impairments early, which is crucial for language and cognitive development.

Innovation and Growth Initiatives:

• Leading provider of Automated Auditory Brainstem Response (AABR) technology

• Integration of telehealth capabilities into diagnostic devices

---

5️⃣ 6. Masimo Corporation

Headquarters: Irvine, California, USA
Key Offering: Pulse Oximetry Monitoring for Critical Congenital Heart Disease (CCHD) Screening

Masimo is a world leader in non-invasive patient monitoring technologies. Their SET® pulse oximetry technology is the gold standard for CCHD screening, a mandatory test in many countries that helps detect life-threatening heart defects before newborns leave the hospital.

Innovation and Growth Initiatives:

• Advanced signal processing algorithms for accurate readings in motion and low perfusion

• Development of wireless and wearable monitoring solutions for continuous care

Download FREE Sample Report:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

4️⃣ 7. Agilent Technologies, Inc.

Headquarters: Santa Clara, California, USA
Key Offering: Mass Spectrometry, Microarrays, and Next-Generation Sequencing Solutions

Agilent Technologies provides a suite of advanced analytical tools that support complex genetic and metabolic testing. Their platforms are used in reference laboratories for confirmatory testing following initial positive screens, ensuring diagnostic accuracy.

Innovation and Growth Initiatives:

• Expansion of SureSeq™ NGS panels for inherited disease testing

• Development of high-resolution mass spectrometry for precise metabolite profiling

---

3️⃣ 8. AB Sciex LLC (Danaher)

Headquarters: Framingham, Massachusetts, USA
Key Offering: High-Performance Mass Spectrometry Systems and Bioinformatics Software

As part of Danaher, AB Sciex offers powerful mass spectrometry solutions trusted by leading clinical laboratories. Their systems deliver the high throughput and reliability required for large-scale newborn screening programs.

Innovation and Growth Initiatives:

• Focus on workflow automation to reduce manual steps and improve lab efficiency

• Development of cloud-based data analytics platforms for collaborative research

---

2️⃣ 9. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Ultrasound Imaging, Patient Monitoring, and Digital Health Solutions

While not exclusively focused on screening, GE Healthcare’s imaging and monitoring technologies play a vital role in the diagnostic journey. Ultrasound systems are used for prenatal screening, and monitoring devices support the care of newborns with detected conditions.

Innovation and Growth Initiatives:

• Integration of AI into imaging systems to aid in the early detection of congenital anomalies

• Development of connected care platforms that link screening data with long-term patient management

---

1️⃣ 10. Medtronic plc (Covidien)

Headquarters: Dublin, Ireland
Key Offering: Nellcor™ Pulse Oximetry Systems for CCHD Screening

Through its Covidien product line, Medtronic is another key supplier of pulse oximetry monitoring technology used for CCHD screening. Their widely adopted Nellcor™ system provides clinicians with reliable data to make critical decisions quickly.

Innovation and Growth Initiatives:

• Ongoing enhancements to oximetry sensor design for neonatal comfort and accuracy

• Research into multi-parameter monitoring systems for comprehensive newborn assessment

Get Full Report Here:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

🧬 Outlook: The Future of Newborn Screening Is Genomic and Digital

The newborn screening market is undergoing a profound transformation. While traditional dried blood spot testing remains fundamental, the industry is rapidly integrating genomic technologies, digital health platforms, and point-of-care diagnostics to create a more comprehensive and connected ecosystem.

📈 Key Trends Shaping the Market:

• Rapid adoption of Whole Exome/Genome Sequencing (WES/WGS) as a second-tier or primary screening tool

• Expansion of screening panels to include rare genetic disorders and immunodeficiencies

• Digitalization of screening workflows with cloud-based data management and telemedicine for follow-up care

• Growing public-private partnerships to increase accessibility in developing regions

Get Full Report Here:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

The companies listed above are not only providing essential diagnostic tools—they are pioneering the precision health revolution for the youngest patients, ensuring every child has the best possible start in life.